An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. [electronic resource]
Producer: 20030701Description: 421-4 p. digitalISSN:- 0160-6689
- Adolescent
- Adrenergic Uptake Inhibitors -- adverse effects
- Adult
- Ambulatory Care
- Antidepressive Agents -- adverse effects
- Comorbidity
- Depressive Disorder -- diagnosis
- Female
- HIV Seropositivity -- epidemiology
- Humans
- Hyperhidrosis -- chemically induced
- Male
- Middle Aged
- Morpholines -- adverse effects
- Nausea -- chemically induced
- Psychiatric Status Rating Scales
- Reboxetine
- Sleep Initiation and Maintenance Disorders -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.